Chloroquine Phosphate Tablets Usp 500 mg 1
Chloroquine Phosphate Tablet
Product Images NDC 0115-7010
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Chloroquine Phosphate (NDC 0115-7010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chloroquine Phosphate Tablets Usp 500 mg 2
Chloroquine phosphate tablets, USP with NDC 0115-7010-09 are intended solely for the treatment of malaria and extraintestinal amebiasis. Each tablet contains Chloroquine Phosphate, USP 500 mg, and the usual dosage should be determined based on the accompanying Prescribing Information. These tablets should be stored between 20° to 25°C (68° to 77°F), and dispensed in a tight, light-resistant container as defined in the USP. This drug is manufactured by Amneal Pharmaceuticals Pvt. Ltd. in Ahmedabad, INDIA, and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. Keep out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
